Healthy Skepticism Library item: 14590
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
MSD Pharma to hire 1,500 people in India
Business Standard 2008 Nov 5
http://business-standard.com/india/storypage.php?autono=48951&tp=on
Full text:
Even as global financial slowdown is forcing companies to retrench jobs, MSD Pharmaceuticals, a subsidiary of US-based Merck & Co, today said it will employ 1,500 people in the next two years to strengthen its sales and marketing network and become a leading company by 2015.
Also Read
News Now
Paper
Specials – Wkly Rev: Sensex gains 176pts – Tata Comm CEO among 10 global influential telecom people – Elder Pharma to market Daiwa’s products – Jharkhand introduces new scheme for farmers – Berkshire Hathaway Q3 net slips 77% $1.06 bn – Jet terminates services of at least 25 expat pilots
More
“We will be doubling our staff strength in India in next two years as part of our plans to consolidate our marketing network in the country, which will further help us achieve our aim of listing among first five pharma companies by 2015,” MSD Pharmaceuticals Managing Director Naveen A Rao said.
At present, the company has a total staff strength of 700 in India.
With an objective of expanding its product portfolio in the country, MSD Pharmaceuticals also plans to launch wide range of vaccines and medicines every six months.
“We have plans to launch our product range including vaccine and medicine which are relevant to India,” he said.
He said that the company would launch its vaccine for hepatitis-A, Chickenpox and rotavirus. In addition, it would also bring out medicines for cardiovascular disease, dyspledemia and asthma.
The company has about six products— four medicines and two vaccine for therapeutic areas namely, critical care, cardiovascular and metabolic at present in the Indian market.
